MentalHealthDaily

Cannabis After Pregnancy Did Not Increase Hypertension Risk in nuMoM2b

by GLOOM

Photoreal illustration of a postpartum woman with stethoscope and cannabis imagery, conveying cardiovascular implications of postpartum cannabis use.

A 2026 nuMoM2b Heart Health Study analysis tested whether urine-confirmed cannabis exposure 2–7 years after a first pregnancy predicted incident stage II hypertension; it did not: adjusted odds ratio (AOR) 1.05, 95% CI 0.63–1.76, with 216 of 4,079 participants developing hypertension.1 Research Highlights The headline result was null: cannabis exposure at the 2–7 year postpartum …

Long Term Effects of Modafinil: Hypothetical Risks & Rewards

by GLOOM

Modafinil (brand name “Provigil”) is a blockbuster eugeroic drug synthesized by Cephalon Pharmaceuticals (now Teva) and approved in 1998 for the treatment of excessive daytime sleepiness (EDS) associated with narcolepsy. It was since approved for the treatment of excessive daytime sleepiness associated with obstructive sleep apnea, as well as to normalize circadian rhythms in diagnoses …